Cargando…
Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010
BACKGROUND: Hemolytic disease of the fetus and newborn (HDFN) is mediated by maternal alloantibodies, a consequence of immune sensitization during pregnancy with maternal-fetal incompatibility with ABO, Rhesus factor (Rh), and/or other red blood cell antigens. RhD, Kell, and other non-ABO alloantibo...
Autores principales: | Yu, Devin, Ling, Leona E., Krumme, Alexis A., Tjoa, May Lee, Moise, Kenneth J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205505/ https://www.ncbi.nlm.nih.gov/pubmed/37229151 http://dx.doi.org/10.1016/j.xagr.2023.100203 |
Ejemplares similares
-
Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape
por: de Winter, Derek P., et al.
Publicado: (2023) -
Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes
por: de Winter, Derek P., et al.
Publicado: (2023) -
Hemolytic disease of the fetus and newborn: Current trends and perspectives
por: Basu, Sabita, et al.
Publicado: (2011) -
Hemolytic disease of the fetus and newborn caused by anti-E
por: Usman, Adiyyatu Sa’idu, et al.
Publicado: (2013) -
Rhesus-D zygosity and hemolytic disease of fetus and newborn
por: Moghaddam, Mostafa, et al.
Publicado: (2013)